期刊文献+

星点设计——效应面法优化复方制剂SY片的制剂工艺

Optimization of Preparation Technology of Compound SY Tablets by Response Surface Methodology-Star Dot Design
下载PDF
导出
摘要 目的采用单因素考察及星点设计——效应面法优化复方制剂SY片的处方。方法采用二因素五水平星点设计,以预胶化淀粉和微晶纤维素的用量为考察因素,崩解时间和硬度为考察指标,分别用线性方程和二项式拟合方程描述崩解时间和硬度指标与影响因素之间的数学关系,根据最佳模型绘制效应面和等高线图,选择最佳处方并进行验证试验。结果二项式方程为Y=18.65-0.86X1-0.8X2-0.08X1X2+0.09X12+0.07X22,表明考察因素和指标之间存在可信的定量关系。经优化后处方中预胶化淀粉和微晶纤维素的用量分别为片重的16、14.8%。结论筛选后的处方工艺验证值与预测值偏差较小,表明该法具有较好的预测性和可靠性。 Objective Using the single-factor investgation and central composite design to optimize the prescription of compound SY pills.Methods Using two-factor and five-level central composite design.Take the amount of pregelatinized starch and microcrystalline cellulose into consideration. Regard the disintegration time and hardness as the indexes, respectively use the linear equation and binomial equation fitting to describe the relationship between the disintegrating time and hardness index as well as influence factors.According to the best model,draw the effect of surface and contour maps. Pick out the best prescription and carry out the experiment. Results Binomial equation for Y = 18.65- 0.86x1- 0.8x2- 0.08x1x2+0.09x12+0.07x22. Which means there is a credible quantitative relationship between the factors and indexes. The optimized prescription of pregelatinized starch and microcrystalline cellulose were 16% and 14.8% of the weight of tablets. Conclusion The prescription process between validation value and value deviation is smaller after screening, which shows that the method has a good predictability and reliability.
出处 《现代中药研究与实践》 CAS 2015年第3期50-52,55,共4页 Research and Practice on Chinese Medicines
关键词 复方制剂SY片 星点设计 效应面 处方优化 Compound SY pills central composite design effect of surface formulation optimization
  • 相关文献

参考文献6

二级参考文献15

  • 1王晓平,廖工铁,侯世祥,王传敏.β-环糊精在六神丸中的应用——2种六神丸的药剂学对比研究[J].中国中药杂志,1993,18(7):415-418. 被引量:22
  • 2高怀生,黄是是,张世达,谷长泉,高兰新.壳聚糖—诺氟沙星烧伤生物敷料及其临床应用[J].医疗卫生装备,1994,15(3):7-9. 被引量:20
  • 3王世岭,孔凡凤.β-CD对水合氯醛稳定性的影响[J].中国药学杂志,1994,29(12):732-734. 被引量:2
  • 4王溶溶,陈丹菲.挥发油β─CD包结物在颗粒剂生产工艺中的研究[J].中成药,1996,18(10):1-2. 被引量:14
  • 5Abu-Izza KA,Garcai-Contreras L,Lu DR.Preparation and evaluation of sustained release AZT-loaded microspheres:optimization of the release characteristics using response surface methodology.J Pharm Sci 1996,85:144
  • 6Molpeceres J,Guzman M,Aberturas MR,et al.Application of central composite design to the preparation of polycaprolactone nanoparticles by solvent displacement.J Pharm Sci 1996,85:206
  • 7MiyazakiS, NakayamaA, OdaM, etal. Drug release fromoral mucosaladnesive tablets of chitosan and sodium alginate[ J]. Int J Pharm, 1995,118:257.
  • 8Mi FL, Wong TB, Shyu SS. Sustaind - release of oxytetracycline from chitosan microspheres prepared by interfacial acylation and spray hardening method [ J ]. J Microencapsulation, 1997, 14: 577.
  • 9Sébastien Branchu,Robert T. Forbes,Peter York,H?kan Nyqvist. A Central Composite Design to Investigate the Thermal Stabilization of Lysozyme[J] 1999,Pharmaceutical Research(5):702~708
  • 10Emad Eldin Hassan,Roy C. Parish,James M. Gallo. Optimized Formulation of Magnetic Chitosan Microspheres Containing the Anticancer Agent, Oxantrazole[J] 1992,Pharmaceutical Research(3):390~397

共引文献447

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部